UBS AG - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$29,000
-32.6%
2,350
-21.2%
0.00%
Q2 2014$43,0000.0%2,981
+43.9%
0.00%
Q1 2014$43,000
+115.0%
2,072
+100.4%
0.00%
Q4 2013$20,000
+1900.0%
1,034
+4036.0%
0.00%
Q3 2013$1,000250.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q3 2014.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders